These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 25077717)
21. A review of facial anatomy as it relates to the use of botulinum toxin. Hatton MP; Rubin PA Int Ophthalmol Clin; 2005; 45(3):39-47. PubMed ID: 15970765 [No Abstract] [Full Text] [Related]
22. Botulinum toxin injection for facial wrinkles. Small R Am Fam Physician; 2014 Aug; 90(3):168-75. PubMed ID: 25077722 [TBL] [Abstract][Full Text] [Related]
23. Saving face. Strategies to fight father time. Cobb C Adv Nurse Pract; 2009 Apr; 17(4):39-43, 68. PubMed ID: 20014725 [No Abstract] [Full Text] [Related]
24. Inability of speculation to explain dose effect differences between botulinum toxin products. Pickett A Arch Facial Plast Surg; 2012 Nov; 14(6):467-8. PubMed ID: 23165908 [No Abstract] [Full Text] [Related]
26. Commentary on Impact of Postreconstitution Room Temperature Storage on the Efficacy of IncobotulinumtoxinA Treatment of Dynamic Lateral Canthus Lines. Lawrence N Dermatol Surg; 2015 Jun; 41(6):718-9. PubMed ID: 25993610 [No Abstract] [Full Text] [Related]
27. Multicentre, randomized, phase III study of a single dose of incobotulinumtoxinA, free from complexing proteins, in the treatment of glabellar frown lines. Fulford-Smith A; Gallagher CJ; Brin MF Dermatol Surg; 2013 Jul; 39(7):1118-9. PubMed ID: 23725480 [No Abstract] [Full Text] [Related]
28. Differences in botulinum toxins: time to end the confusion. Brin MF; Tan K; Gallagher C J Cosmet Laser Ther; 2009 Sep; 11(3):180-1. PubMed ID: 19626521 [No Abstract] [Full Text] [Related]
29. Reply to discussion by Dr. M. Kane. Harii K; Kawashima M Aesthetic Plast Surg; 2010 Jun; 34(3):401-3. PubMed ID: 20186416 [No Abstract] [Full Text] [Related]
30. Antibody-induced failure of botulinum toxin a therapy in cosmetic indications. Dressler D; Wohlfahrt K; Meyer-Rogge E; Wiest L; Bigalke H Dermatol Surg; 2010 Dec; 36 Suppl 4():2182-7. PubMed ID: 21134050 [TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin a for the treatment of hyperkinetic wrinkle lines. Park MY; Ahn KY Plast Reconstr Surg; 2003 Oct; 112(5 Suppl):148S-150S. PubMed ID: 14504497 [No Abstract] [Full Text] [Related]
32. Neuromodulators: available agents, physiology, and anatomy. Nettar K; Maas C Facial Plast Surg; 2011 Dec; 27(6):517-22. PubMed ID: 22205524 [TBL] [Abstract][Full Text] [Related]
33. Current concepts in lip augmentation. Mannino GN; Lipner SR Cutis; 2016 Nov; 98(5):325-329. PubMed ID: 28040807 [TBL] [Abstract][Full Text] [Related]
34. Botulinum toxin for glabellar lines: a review of the efficacy and safety of currently available products. Dessy LA; Fallico N; Mazzocchi M; Scuderi N Am J Clin Dermatol; 2011 Dec; 12(6):377-88. PubMed ID: 21877763 [TBL] [Abstract][Full Text] [Related]
35. Upper- and mid-face anti-aging treatment and prevention using onabotulinumtoxin A: the 2010 multidisciplinary French consensus--part 1. Raspaldo H; Baspeyras M; Bellity P; Dallara JM; Gassia V; Niforos FR; Belhaouari L; J Cosmet Dermatol; 2011 Mar; 10(1):36-50. PubMed ID: 21332914 [TBL] [Abstract][Full Text] [Related]
36. Commentary on Evolution of Facial Aesthetic Treatment Over Five or More Years. Jagdeo J Dermatol Surg; 2015 Jul; 41(7):848-9. PubMed ID: 26035045 [No Abstract] [Full Text] [Related]
37. A Systematic Review of Patient-Reported Outcomes for Cosmetic Indications of Botulinum Toxin Treatment. Wang J; Rieder EA Dermatol Surg; 2019 May; 45(5):668-688. PubMed ID: 30893170 [TBL] [Abstract][Full Text] [Related]